Allogene Therapeutics, Inc. (ALLO)
USD 1.7
(0.59%)
USD 1.7
(0.59%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -300.29 Million USD | 14.43% |
| 2022 | -321.24 Million USD | -31.14% |
| 2021 | -169.73 Million USD | 0.95% |
| 2020 | -250.8 Million USD | -39.65% |
| 2019 | -179.89 Million USD | 11.21% |
| 2018 | -206.76 Million USD | -10413100.0% |
| 2017 | 22 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -65.94 Million USD | 3.66% |
| 2024 Q2 | -62.79 Million USD | 4.78% |
| 2023 Q4 | -68.45 Million USD | -15.23% |
| 2023 FY | - USD | 14.43% |
| 2023 Q3 | -59.4 Million USD | 22.73% |
| 2023 Q2 | -76.87 Million USD | 22.4% |
| 2023 Q1 | -99.07 Million USD | -2.8% |
| 2022 Q3 | -78.62 Million USD | -7.83% |
| 2022 Q2 | -72.91 Million USD | 4.43% |
| 2022 Q1 | -76.3 Million USD | -3.26% |
| 2022 Q4 | -96.37 Million USD | -22.57% |
| 2022 FY | - USD | -31.14% |
| 2021 FY | - USD | 0.95% |
| 2021 Q1 | -31.28 Million USD | 54.9% |
| 2021 Q4 | -73.89 Million USD | 1.92% |
| 2021 Q3 | -75.34 Million USD | -9.09% |
| 2021 Q2 | -69.06 Million USD | -120.77% |
| 2020 Q3 | -68.04 Million USD | -11.05% |
| 2020 Q1 | -55.63 Million USD | 9.06% |
| 2020 FY | - USD | -39.65% |
| 2020 Q4 | -69.36 Million USD | -1.94% |
| 2020 Q2 | -61.27 Million USD | -10.12% |
| 2019 Q3 | -49.37 Million USD | -7.43% |
| 2019 Q2 | -45.96 Million USD | -28.5% |
| 2019 Q1 | -35.76 Million USD | -16.78% |
| 2019 FY | - USD | 11.21% |
| 2019 Q4 | -61.18 Million USD | -23.92% |
| 2018 Q4 | -30.62 Million USD | 22.73% |
| 2018 Q2 | -134.56 Million USD | -5081.44% |
| 2018 Q1 | -2.59 Million USD | -129750.0% |
| 2018 FY | - USD | -10413100.0% |
| 2018 Q3 | -39.63 Million USD | 70.54% |
| 2017 Q4 | -2000.00 USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -243.479% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -130.249% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -103093.471% |
| Autolus Therapeutics plc | -156.77 Million USD | -91.55% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3120.558% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -964.152% |
| Shattuck Labs, Inc. | -87.61 Million USD | -242.742% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -145.651% |
| CervoMed Inc. | -2.17 Million USD | -13726.447% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -26.908% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -575.777% |
| Aptose Biosciences Inc. | -52.26 Million USD | -474.526% |
| Precision BioSciences, Inc. | -32.04 Million USD | -837.186% |
| Dyadic International, Inc. | -8.22 Million USD | -3548.876% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -274.907% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -2877.325% |
| Nektar Therapeutics | -243.1 Million USD | -23.523% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -6868.972% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -926.362% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -335.201% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -270.792% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -58.656% |
| GRI Bio, Inc. | -10.89 Million USD | -2655.487% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -6549.955% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -145.125% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2724.161% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -10813.475% |
| IGM Biosciences, Inc. | -253.35 Million USD | -18.525% |
| INmune Bio, Inc. | - USD | Infinity% |
| Opthea Limited | -200.01 Million USD | -50.132% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -428.266% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -221.203% |
| Verastem, Inc. | -83.16 Million USD | -261.077% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -493.793% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -89.785% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -163.209% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 395.195% |
| NextCure, Inc. | -59.03 Million USD | -408.635% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1408.071% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1928.185% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 9363773.215% |
| Arvinas, Inc. | -394.8 Million USD | 23.938% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -411.458% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1294.183% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -360.029% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -80.827% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1142.626% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -91.032% |
| Senti Biosciences, Inc. | -61.33 Million USD | -389.587% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1894.634% |
| Apollomics, Inc. | -171.74 Million USD | -74.846% |
| PureTech Health plc | -11.62 Million USD | -2482.721% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 13535.928% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -301.381% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -109.7% |
| Synaptogenix, Inc. | -8.3 Million USD | -3514.719% |
| ChromaDex Corporation | -3.89 Million USD | -7611.685% |
| Beam Therapeutics Inc. | -156.47 Million USD | -91.914% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 70092.005% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -4272.35% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -112.358% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 39.361% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 121569.889% |
| Gritstone bio, Inc. | -126.86 Million USD | -136.707% |
| Mesoblast Limited | -61.33 Million USD | -389.627% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -13248.023% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1165.191% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -74.357% |
| MediWound Ltd. | -4.89 Million USD | -6037.196% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -81.533% |
| Fortress Biotech, Inc. | -133.64 Million USD | -124.698% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -494.051% |
| Achilles Therapeutics plc | -70.44 Million USD | -326.298% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -251.491% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -475.848% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -857.75% |
| Zai Lab Limited | -366.57 Million USD | 18.081% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -5216.802% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -33.316% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2644.407% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -128.065% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -4151.075% |
| FibroGen, Inc. | -261.4 Million USD | -14.877% |
| Celcuity Inc. | -58.3 Million USD | -414.994% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2595.386% |
| ContextLogic Inc. | -324 Million USD | 7.317% |
| GH Research PLC | -41.15 Million USD | -629.699% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -288.261% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1081.233% |
| ImmuCell Corporation | -2.5 Million USD | -11892.163% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 852.803% |
| Amarin Corporation plc | -50.9 Million USD | -489.949% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1250.548% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -960.694% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -362.096% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -187.486% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1069.73% |
| Aptorum Group Limited | -9.59 Million USD | -3028.379% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 41.855% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -158.128% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1082.628% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -70.94% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1570.759% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -138.619% |
| Ardelyx, Inc. | -55.35 Million USD | -442.496% |
| Ainos, Inc. | -8.77 Million USD | -3322.884% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -360.219% |
| Prothena Corporation plc | -190.1 Million USD | -57.959% |
| HilleVax, Inc. | -132.46 Million USD | -126.694% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -134.242% |
| Celularity Inc. | -183.94 Million USD | -63.251% |
| Rallybio Corporation | -72.37 Million USD | -314.924% |
| Cue Biopharma, Inc. | -46.05 Million USD | -552.074% |
| Omeros Corporation | -163.61 Million USD | -83.542% |
| Humacyte, Inc. | -96.45 Million USD | -211.32% |
| Immunocore Holdings plc | -59.64 Million USD | -403.433% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1450.139% |
| Blueprint Medicines Corporation | -474.61 Million USD | 36.729% |
| IO Biotech, Inc. | -91.22 Million USD | -229.168% |
| MEI Pharma, Inc. | 26.38 Million USD | 1238.336% |
| GT Biopharma, Inc. | 5.97 Million USD | 5122.462% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -310.046% |
| Summit Therapeutics Inc. | 1 Million USD | 30099.301% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -871.696% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -139.283% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -78.267% |
| Pulmatrix, Inc. | -12.64 Million USD | -2274.609% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -810.917% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -180.378% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -239.441% |
| Acelyrin, Inc. | -381.52 Million USD | 21.292% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 40.69% |
| Cytokinetics, Incorporated | -456.68 Million USD | 34.245% |
| Vor Biopharma Inc. | -114.37 Million USD | -162.56% |
| Evogene Ltd. | -23.2 Million USD | -1194.143% |
| Replimune Group, Inc. | -230.19 Million USD | -30.45% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -365.318% |
| PDS Biotechnology Corporation | -40.08 Million USD | -649.141% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -195978.982% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 46.895% |
| AEON Biopharma, Inc. | -48.36 Million USD | -520.94% |
| BioLineRx Ltd. | -57.06 Million USD | -426.267% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -148559.901% |
| Atai Life Sciences N.V. | -36.31 Million USD | -727.003% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -269.305% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -825.317% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -8.998% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -876.88% |
| MediciNova, Inc. | -9.87 Million USD | -2939.412% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -138.439% |
| MiMedx Group, Inc. | 40.51 Million USD | 841.153% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -19524.415% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -33.469% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 9.096% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1052.491% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -30.595% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -900.143% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -28.618% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6167.247% |
| Allakos Inc. | -189.91 Million USD | -58.12% |
| scPharmaceuticals Inc. | -46.06 Million USD | -551.946% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -176.788% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 377.217% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2445.793% |
| Precigen, Inc. | -89.22 Million USD | -236.553% |
| XOMA Corporation | -39.36 Million USD | -662.901% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -202.55% |
| Incyte Corporation | 919.42 Million USD | 132.661% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -2937.28% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -155.243% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -258.281% |
| Seer, Inc. | -97.88 Million USD | -206.781% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1145.414% |
| CRISPR Therapeutics AG | -202.7 Million USD | -48.146% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -102.039% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2099.465% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -3633.919% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1687.246% |
| Novavax, Inc. | -487.39 Million USD | 38.388% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -4600.432% |
| UroGen Pharma Ltd. | -63.83 Million USD | -370.45% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -342.16% |
| Entera Bio Ltd. | -8.8 Million USD | -3310.87% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1076.743% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -167.393% |
| Chimerix, Inc. | -92.97 Million USD | -222.986% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -265.173% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -88.805% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -423.378% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 120.718% |
| AnaptysBio, Inc. | -143.16 Million USD | -109.755% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2002.935% |
| Portage Biotech Inc. | -18.19 Million USD | -1550.052% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -187.131% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -280.72% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1907022.312% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2557.375% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -3501.497% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2521.081% |
| AbCellera Biologics Inc. | -192.15 Million USD | -56.274% |
| Genprex, Inc. | -31.06 Million USD | -866.798% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -60.134% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2445.793% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 199096.05% |
| Daré Bioscience, Inc. | -30.7 Million USD | -878.105% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -4091.11% |
| Bicycle Therapeutics plc | -183.4 Million USD | -63.737% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 30.259% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -232.403% |
| Erasca, Inc. | -121.31 Million USD | -147.542% |
| bluebird bio, Inc. | -167.16 Million USD | -79.643% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1219.273% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 196.78% |
| DBV Technologies S.A. | -85.98 Million USD | -249.251% |
| Fortress Biotech, Inc. | -133.64 Million USD | -124.698% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -28.607% |
| CorMedix Inc. | -48.88 Million USD | -514.259% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 7.955% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -799.458% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -486.292% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -533.984% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -115.985% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -27.749% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -45.872% |
| Onconetix, Inc. | -36.7 Million USD | -718.087% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -2912.57% |
| Prime Medicine, Inc. | -193.75 Million USD | -54.983% |
| Adagene Inc. | -14.95 Million USD | -1908.543% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -45.285% |
| GlycoMimetics, Inc. | -39.12 Million USD | -667.581% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 142.152% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -37.959% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 337.47% |
| SciSparc Ltd. | -5.28 Million USD | -5585.214% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -315307.319% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1284.386% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -261.668% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1205.889% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 159232.725% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -32.035% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2446.524% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -16.284% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2819.718% |
| 2seventy bio, Inc. | -206.41 Million USD | -45.478% |
| ADMA Biologics, Inc. | 5.12 Million USD | 5965.098% |
| Clene Inc. | -43.24 Million USD | -594.464% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1205.112% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -519.455% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -0.243% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -717.583% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1373.885% |
| Absci Corporation | -95.45 Million USD | -214.585% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 106.452% |
| Surrozen, Inc. | -41.13 Million USD | -630.089% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -166.846% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -322.805% |
| Cingulate Inc. | -22.95 Million USD | -1208.35% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -3924.836% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -3550.37% |
| Jaguar Health, Inc. | -33.13 Million USD | -806.381% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -193.639% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -342.734% |
| Kronos Bio, Inc. | -121.83 Million USD | -146.485% |
| Innoviva, Inc. | 248.96 Million USD | 220.619% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -303.935% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -93449.221% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -178.711% |
| Soligenix, Inc. | -7.85 Million USD | -3724.0% |
| AlloVir, Inc. | -190.14 Million USD | -57.928% |
| Century Therapeutics, Inc. | -121.2 Million USD | -147.75% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -173.62% |
| Kura Oncology, Inc. | -164.95 Million USD | -82.045% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -31254.367% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -254.717% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1406.436% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 56866.163% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -189.322% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -687.484% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1858.743% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1807.441% |
| HCW Biologics Inc. | -23.57 Million USD | -1173.72% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -145.934% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -12.893% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -54.839% |
| Lantern Pharma Inc. | -15.78 Million USD | -1802.191% |
| Histogen Inc. | -10.5 Million USD | -2759.116% |
| Surrozen, Inc. | -41.13 Million USD | -630.089% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Kodiak Sciences Inc. | -259.02 Million USD | -15.933% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -454.968% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -509.627% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -166.692% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -974.201% |
| Moderna, Inc. | -3.28 Billion USD | 90.853% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -30.556% |
| Turnstone Biologics Corp. | -56.23 Million USD | -434.006% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1761.054% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1857.709% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -376.3% |
| Exelixis, Inc. | 196.6 Million USD | 252.742% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -119.05% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -410.789% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -92583.025% |
| Alkermes plc | 495.04 Million USD | 160.659% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -362.096% |
| Arcellx, Inc. | -64.14 Million USD | -368.147% |
| ESSA Pharma Inc. | -26.45 Million USD | -1035.095% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7407.426% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2515.565% |
| Insmed Incorporated | -654.73 Million USD | 54.135% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -567.11% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -143.199% |
| Moolec Science SA | -52.07 Million USD | -476.649% |
| RenovoRx, Inc. | -11.39 Million USD | -2536.462% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -481.896% |
| Geron Corporation | -174.78 Million USD | -71.81% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -642.987% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -382.809% |
| Royalty Pharma plc | 1.88 Billion USD | 115.911% |
| OmniAb, Inc. | -49.73 Million USD | -503.835% |
| Alector, Inc. | -142.89 Million USD | -110.154% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -151.096% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -80.812% |
| Humacyte, Inc. | -96.45 Million USD | -211.32% |
| Structure Therapeutics Inc. | -102.45 Million USD | -193.086% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -3.322% |
| 89bio, Inc. | -134.46 Million USD | -123.328% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 7510.982% |
| Aura Biosciences, Inc. | -83.69 Million USD | -258.79% |
| Immunic, Inc. | -99.11 Million USD | -202.983% |
| Veracyte, Inc. | -49.4 Million USD | -507.77% |
| Genelux Corporation | -24.16 Million USD | -1142.677% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -788.441% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4189.086% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1504.398% |
| Immunovant, Inc. | -269.97 Million USD | -11.229% |
| Vericel Corporation | 2.86 Million USD | 10585.091% |
| Fortrea Holdings Inc. | 167.3 Million USD | 279.494% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -123.632% |
| XBiotech Inc. | -35.76 Million USD | -739.605% |
| Agenus Inc. | -145.92 Million USD | -105.787% |
| Acasti Pharma Inc. | -11.3 Million USD | -2557.225% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2331.518% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1249.435% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1858.743% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -634.806% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -436.036% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1791.014% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1254.529% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -943.554% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -936.816% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -78.254% |
| United Therapeutics Corporation | 1.38 Billion USD | 121.654% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -5334.628% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -6193.16% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 9363773.215% |
| Silo Pharma, Inc. | -3.62 Million USD | -8181.171% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -4809.519% |
| Pharming Group N.V. | 9.87 Million USD | 3140.326% |
| XOMA Corporation | -39.36 Million USD | -662.901% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1145.414% |
| Bionomics Limited | -9.83 Million USD | -2952.69% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -767.748% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -282.573% |
| uniQure N.V. | -253.1 Million USD | -18.646% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -306.879% |
| Cassava Sciences, Inc. | -95.68 Million USD | -213.828% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -20950.37% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1389.623% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -131.879% |
| Pluri Inc. | -20.22 Million USD | -1384.761% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -3630.129% |
| MeiraGTx Holdings plc | -57.05 Million USD | -426.35% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1132.477% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1586.122% |
| CalciMedica, Inc. | -34.18 Million USD | -778.332% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -18.98% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -226.125% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2330482.566% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -767.748% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -196.688% |
| Nutriband Inc. | -5.12 Million USD | -5763.063% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -593.966% |
| Compugen Ltd. | -12.51 Million USD | -2299.273% |
| Roivant Sciences Ltd. | -996.51 Million USD | 69.866% |
| ProKidney Corp. | -147.66 Million USD | -103.355% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -6575.023% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -6932.058% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -168.699% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -277.646% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -517.912% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1235.229% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1026.01% |
| Biomea Fusion, Inc. | -124.62 Million USD | -140.967% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -57.767% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -180.339% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1213.905% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1211.495% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -23.933% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -44.486% |
| Imunon, Inc. | -19.87 Million USD | -1410.659% |
| BioAtla, Inc. | -122.24 Million USD | -145.657% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -624.523% |
| Zura Bio Limited | -60.56 Million USD | -395.836% |
| aTyr Pharma, Inc. | -52.17 Million USD | -475.517% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 20.969% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -28.021% |
| Galecto, Inc. | -37.51 Million USD | -700.376% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 159232.725% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 166.444% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -83.706% |
| PolyPid Ltd. | -20.26 Million USD | -1381.977% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1823.352% |
| Forte Biosciences, Inc. | -32.47 Million USD | -824.633% |
| Xencor, Inc. | -125.87 Million USD | -138.566% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1389.725% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -4600.432% |
| Instil Bio, Inc. | -146.12 Million USD | -105.508% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -19524.415% |
| OncoCyte Corporation | -23.12 Million USD | -1198.677% |
| Elevation Oncology, Inc. | -41.46 Million USD | -624.173% |
| Purple Biotech Ltd. | -22.22 Million USD | -1251.15% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -4584.758% |
| MacroGenics, Inc. | 2.01 Million USD | 14988.101% |
| Verona Pharma plc | -52.46 Million USD | -472.34% |
| Tharimmune, Inc. | -9.3 Million USD | -3128.058% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -257.556% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -216.858% |
| Aditxt, Inc. | -25.45 Million USD | -1079.564% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -39205.366% |
| Savara Inc. | -59.13 Million USD | -407.826% |
| Curis, Inc. | -45.13 Million USD | -565.263% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1876.763% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1023.263% |
| BeiGene, Ltd. | -1.12 Billion USD | 73.298% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -6575.023% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -604.764% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2265.816% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -401.726% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1668.406% |
| Adicet Bio, Inc. | -136.53 Million USD | -119.938% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4007.92% |
| Quantum-Si incorporated | -91.8 Million USD | -227.102% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Generation Bio Co. | -133.3 Million USD | -125.276% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -249.085% |
| Invivyd, Inc. | -196.61 Million USD | -52.731% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 19.741% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3137.731% |
| Moolec Science SA | -52.07 Million USD | -476.649% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1202.338% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -429.113% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 6215.629% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -89.574% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 56.117% |
| Evaxion Biotech A/S | -21.4 Million USD | -1303.042% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -352.146% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -277.29% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -705.442% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -414.447% |
| Clearmind Medicine Inc. | -8.71 Million USD | -3347.419% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -359.409% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 445.912% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -12199.962% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -197.83% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -97.331% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -35.566% |
| ImmunityBio, Inc. | -436.18 Million USD | 31.154% |
| Korro Bio, Inc. | -80.9 Million USD | -271.172% |
| Kineta, Inc. | -15.71 Million USD | -1810.99% |
| BioVie Inc. | -31.95 Million USD | -839.878% |
| Codexis, Inc. | -49.28 Million USD | -509.324% |
| Celularity Inc. | -183.94 Million USD | -63.251% |
| Virax Biolabs Group Limited | -6.6 Million USD | -4443.599% |
| Cibus, Inc. | -314.58 Million USD | 4.543% |
| Annexon, Inc. | -141.57 Million USD | -112.109% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -367.775% |
| Eyenovia, Inc. | -24.1 Million USD | -1145.717% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 770.536% |
| NeurAxis, Inc. | -6.66 Million USD | -4405.863% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -872.388% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -519.506% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1347.84% |
| Notable Labs, Ltd. | -14.4 Million USD | -1985.368% |
| IN8bio, Inc. | -28.5 Million USD | -953.512% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1455.278% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -194.37% |
| Lumos Pharma, Inc. | -36.57 Million USD | -721.146% |
| Liquidia Corporation | -70.05 Million USD | -328.678% |
| Mustang Bio, Inc. | -48.06 Million USD | -524.79% |
| Quantum-Si incorporated | -91.8 Million USD | -227.102% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -323.031% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -216.858% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -345.228% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1256.703% |
| Vaxcyte, Inc. | -464.88 Million USD | 35.405% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -42.648% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4007.92% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -952.072% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 5251.489% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -12199.962% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -710.945% |
| PepGen Inc. | -83.58 Million USD | -259.28% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -917.804% |
| Solid Biosciences Inc. | -93.43 Million USD | -221.396% |
| Palisade Bio, Inc. | -12.28 Million USD | -2345.184% |
| Nutriband Inc. | -5.12 Million USD | -5763.063% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -92583.025% |
| Immuneering Corporation | -58.06 Million USD | -417.204% |
| Belite Bio, Inc | -31.52 Million USD | -852.434% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -441.732% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1026.01% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -561.788% |
| Altimmune, Inc. | -87.93 Million USD | -241.494% |
| Peak Bio, Inc. | -1356.23 USD | -22141645.869% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2595.386% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1788.516% |
| Neurogene Inc. | -52.28 Million USD | -474.328% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -120.011% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -3476.62% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -222.833% |
| Sesen Bio, Inc. | -50.84 Million USD | -490.663% |
| argenx SE | -216.02 Million USD | -39.01% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -952.072% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -523.351% |
| Immunome, Inc. | -28.27 Million USD | -962.194% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1652.003% |
| Design Therapeutics, Inc. | -66.32 Million USD | -352.76% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -695.478% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -266.515% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 29.745% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -185.458% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -130.302% |
| Athira Pharma, Inc. | -116.7 Million USD | -157.314% |
| XOMA Corporation | -39.36 Million USD | -662.901% |
| Merus N.V. | -149.2 Million USD | -101.259% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -860.63% |
| Rezolute, Inc. | -68.42 Million USD | -338.877% |
| Clene Inc. | -43.24 Million USD | -594.464% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1847.149% |
| BeyondSpring Inc. | -21.54 Million USD | -1294.118% |
| Synlogic, Inc. | -55.16 Million USD | -444.394% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2385.252% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2721.772% |
| Peak Bio, Inc. | -1356.23 USD | -22141645.869% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -824.975% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1777.24% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -153.577% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 12.027% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -6418.993% |
| MannKind Corporation | 15.12 Million USD | 2084.883% |
| Ikena Oncology, Inc. | -74.39 Million USD | -303.636% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2284.603% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1577.311% |
| Gossamer Bio, Inc. | -172.15 Million USD | -74.435% |
| CohBar, Inc. | -12.06 Million USD | -2388.803% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1077.204% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -900.143% |
| Legend Biotech Corporation | -477.87 Million USD | 37.161% |
| Mural Oncology plc | -192.72 Million USD | -55.818% |
| Disc Medicine, Inc. | -91.02 Million USD | -229.902% |
| Champions Oncology, Inc. | -5.05 Million USD | -5841.69% |
| REGENXBIO Inc. | -239.46 Million USD | -25.402% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2701.715% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -438.584% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -674.585% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -166.203% |
| Vaxart, Inc. | -74.72 Million USD | -301.875% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -752.904% |
| Cellectis S.A. | -98.09 Million USD | -206.125% |
| Longeveron Inc. | -20.06 Million USD | -1396.974% |
| Repare Therapeutics Inc. | -114.27 Million USD | -162.786% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 31.627% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -301.397% |
| Revolution Medicines, Inc. | -430.58 Million USD | 30.259% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -4674.893% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -875.326% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -302.592% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 6224.679% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2638.65% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 106.521% |
| Denali Therapeutics Inc. | -179.97 Million USD | -66.854% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -315307.319% |
| Veru Inc. | -89.97 Million USD | -233.749% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1017.245% |
| Cingulate Inc. | -22.95 Million USD | -1208.35% |
| Passage Bio, Inc. | -98.34 Million USD | -205.359% |
| Context Therapeutics Inc. | -25.06 Million USD | -1098.269% |
| Exicure, Inc. | -15.53 Million USD | -1832.512% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -45.728% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -712.129% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -4936.279% |
| Nuvalent, Inc. | -149.49 Million USD | -100.876% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -3592.544% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -249.609% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -895.073% |
| OmniAb, Inc. | -49.73 Million USD | -503.835% |
| Anew Medical, Inc. | -1.3 Million USD | -22984.545% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2328.769% |
| Lipocine Inc. | -16.32 Million USD | -1739.73% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -350.417% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -304.147% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -687.484% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -669.706% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1253.708% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 44.907% |
| Ocugen, Inc. | -64.82 Million USD | -363.222% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -224.396% |
| Q32 Bio Inc. | -86.5 Million USD | -247.152% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1674.047% |
| Alumis Inc. Common Stock | -156.89 Million USD | -91.404% |
| Equillium, Inc. | -12.13 Million USD | -2373.991% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -413.567% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3699.566% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1492.139% |
| Dominari Holdings Inc. | -22.44 Million USD | -1238.204% |
| Edesa Biotech, Inc. | -8.19 Million USD | -3566.518% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1081.698% |
| Bio-Techne Corporation | 326.66 Million USD | 191.927% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 21.974% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 238.775% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -129.042% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -702.257% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -98.737% |
| Nkarta, Inc. | -120.48 Million USD | -149.245% |
| BioCardia, Inc. | -11.56 Million USD | -2497.69% |
| Iterum Therapeutics plc | -34.58 Million USD | -768.401% |